FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause

[FDA]

The FDA approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause. Veozah is the first neurokinin 3 receptor antagonist approved by the FDA to treat moderate to severe hot flashes from menopause.


Baca selengkapnya di : http://www.fda.gov...